“To address the specific needs of medical imaging clinical engineering departments nationwide, Siemens Healthineers has introduced Share360, a flexible in-house service portfolio.”
Visit Website“GE Healthcare and Dutch-based cardiovascular imaging software provider Medis announced at the 2017 Transcatheter Cardiovascular Therapeutics (TCT) annual conference a new collaboration agreement to increase the clinical availability and adoption of Medis Suite QAngio XA 3D, a proprietary image-based fractional flow reserve (FFR) technology.”
Visit Website“A discussion with Peter L. Duffy, M.D., MMM, FACC, FSCAI CPE, interventional cardiologist and former director of quality for the cardiovascular service line at FirstHealth of the Carolinas Reid Heart Institute, at Moore Regional Hospital in Pinehurst, N.C.”
Visit Website“TherOx Inc. announced that results of its IC-HOT (Evaluation of Intracoronary Hyperoxemic Oxygen Therapy) study successfully met its primary endpoint.”
Visit Website“From numerous high-quality submissions, Transcatheter Cardiovascular Therapeutics (TCT) has selected 12 late-breaking clinical trials and 16 first report Investigations that are guaranteed to impact patient care and future directions in cardiovascular technologies.”
Visit Website“In the Society for Cardiovascular Angiography and Interventions’ (SCAI) comment letter to the Centers for Medicare & Medicaid Services (CMS) regarding the 2018 Hospital Outpatient Prospective Payment System (HOPPS) proposed rule, SCAI took the opportunity to ask CMS to add the acute myocardial infarction percutaneous coronary intervention (AMI-PCI) Current Procedural Terminology (CPT) code (92941) to the inpatient-only (IPO) list.”
Visit Website“4C Medical Technologies Inc. announced that its medical device for mitral regurgitation (MR) was presented at the Shark Tank Innovation Competition at the Transcatheter Cardiovascular Therapeutics (TCT) meeting, held Oct. 29-Nov. 2, 2017 in Denver.”
Visit Website“Abbott today received European CE mark for Xience Sierra, the newest generation of the company’s Xience everolimus-eluting coronary stent system. CE mark allows sale of the device in the European Union and other countries that recognize CE mark.”
Visit Website“A discussion with William W. O’Neill, M.D., medical director, Center for Structural Heart Disease, Henry Ford Hospital, Detroit, about the creation of a national initiative to start percutaneous hemodynamic support first before beginning revascularization.”
Visit Website“New results from the HARMONEE Japan/U.S. Registration Trial, reported by in a first report investigations session at the 2017 Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, demonstrate that the OrbusNeich Combo Dual-therapy Stent (DTS) compares favorably to the market-leading Abbott Xience stent for treating patients with significant ischemic heart disease.”
Visit Website